Business description: TearLab Corporation

TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Sales by Activity: TearLab Corporation

Fiscal Period: December 2019 (USD)

Diagnostic Kits / Equipment

22.66M

Geographical breakdown of sales: TearLab Corporation

Fiscal Period: December 2019 (USD)

United States

21.29M

Rest of the World

1.37M

Executive Committee: TearLab Corporation

Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
Chief Tech/Sci/R&D Officer - 2009-07-16
Director of Finance/CFO 60 2022-06-30
Chief Tech/Sci/R&D Officer - 2006-09-30
Chief Tech/Sci/R&D Officer 73 -

Composition of the Board of Directors: TearLab Corporation

Director TitleAgeSince
Director/Board Member 58 2020-07-08
Chairman 68 2021-12-08
Director/Board Member 78 2004-08-31
Director/Board Member 62 -
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -

Company details: TearLab Corporation

TearLab Corp., Inc.

940 South Kimball Avenue

76092, Southlake

+855-832-7522

http://www.tearlab.com
address TearLab Corporation

Glasses, Spectacles & Contact Lenses

Change 5-day change 1-year change 3-year change Capi.($)
+1.56%+2.41%-14.09%+12.32% 184B
-6.38%-4.98%-18.07%+8.01% 112B
-0.59%+1.18%+6.44%+36.82% 118B
+3.42%+1.71%-41.92%+8.01% 94.58B
+0.09%-0.05%-2.06%+78.69% 63.13B
-0.46%+0.42%+4.48%+82.84% 55.66B
-0.23%-0.52%+10.73%-21.72% 53.9B
-4.30%-1.64%-12.44%+37.99% 43.42B
+0.58%+2.00%-1.17%-8.82% 34.68B
Average -0.70%+0.06%-7.57%+26.01% 84.36B
Weighted average by Cap. -0.49%+0.23%-10.14%+23.73%
  1. Stock Market
  2. Stocks
  3. Stock
  4. Company TearLab Corporation